MEDASENSE

Medasense is transforming the way PAIN is being assessed and treated worldwide with its AI technology and sensing platform... Medasense's technology and development strategy address pain management in diverse settings - a $20B market... Through our breakthrough NOL® AI technology and sensor platform, we quantify pain response to optimize care and avoid overmedication. Medasense's flagship product, PMD-200™, is used in critical care settings, to visualize pain response and personalize treatment. Our pipeline products apply Medasense's AI capabilities to lead pain prediction, stratification and prevention strategies.

Also known as: Medasense Biometrics, Medasense Biometrics Ltd.

Primary location: Ramat Gan Israel